Genetic Predictors of Progressive Multifocal Leukoencephalopathy
The implementation of genetic testing for patients prescribed medications associated with progressive multifocal leukoencephalopathy is likely to improve safety outcomes.
Stay updated with breaking news from Pharmd Candidate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The implementation of genetic testing for patients prescribed medications associated with progressive multifocal leukoencephalopathy is likely to improve safety outcomes.
Different guidelines have notable differences between equivalency dosing of proton pump inhibitors (PPI), resulting in confusion and a lack of confidence between medical professionals recommending one PPI over another.
/PRNewswire/ -- Congratulations to Kathryn DeStefano, Matthew Dickson, and Weston Schmutz, the recipients of AMCP Foundation's Best Poster Awards at Nexus 2022....
/PRNewswire/ -- Congratulations to Kathryn DeStefano, Matthew Dickson, and Weston Schmutz, the recipients of AMCP Foundation's Best Poster Awards at Nexus 2022....
ALEXANDRIA, Va., Nov. 17, 2022 /PRNewswire/ -- Congratulations to Kathryn DeStefano, Matthew Dickson, and Weston Schmutz, the recipients of AMCP F...